Integration of host strain bioengineering and bioprocess development using ultra-scale down studies to select the optimum combination: an antibody fragment primary recovery case study.
An ultra scale-down primary recovery sequence was established for a platform E. coli Fab production process. It was used to evaluate the process robustness of various bioengineered strains. Centrifugal discharge in the initial dewatering stage was determined to be the major cause of cell breakage. The ability of cells to resist breakage was dependant on a combination of factors including host strain, vector, and fermentation strategy. Periplasmic extraction studies were conducted in shake flasks and it was demonstrated that key performance parameters such as Fab titre and nucleic acid concentrations were mimicked. The shake flask system also captured particle aggregation effects seen in a large scale stirred vessel, reproducing the fine particle size distribution that impacts the final centrifugal clarification stage. The use of scale-down primary recovery process sequences can be used to screen a larger number of engineered strains. This can lead to closer integration with and better feedback between strain development, fermentation development, and primary recovery studies.
Bioprocess Research and Development, Novartis Phama AG, Basel, Switzerland. jean.aucamp@novartis.com.
Jean P
JP
Aucamp
Richard
R
Davies
Damien
D
Hallet
Amanda
A
Weiss
Nigel J
NJ
Titchener-Hooker
D057005:Bioengineering / Q000295:instrumentation; D019149:Bioreactors; D002498:Centrifugation; D004867:Equipment Design; D004926:Escherichia coli / Q000166:cytology / Q000235:genetics*; D007140:Immunoglobulin Fab Fragments / Q000235:genetics* / Q000302:isolation & purification*; D007128:Immunoglobulin Fragments; D007218:Industrial Microbiology / Q000295:instrumentation*
D007140:Immunoglobulin Fab Fragments; D007128:Immunoglobulin Fragments
antibody fragment; primary recovery; strain development; ultra scale-down